APA

Bell I. M., Erb J. M., Freidinger R. M., Gallicchio S. N., Guare J. P., Guidotti M. T., Halpin R. A., Hobbs D. W., Homnick C. F., Kuo M. S., Lis E. V., Mathre D. J., Michelson S. R., Pawluczyk J. M., Pettibone D. J., Reiss D. R., Vickers S., Williams P. D. & Woyden C. J. (19980624). Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines. : Journal of medicinal chemistry.

Chicago

Bell I M, Erb J M, Freidinger R M, Gallicchio S N, Guare J P, Guidotti M T, Halpin R A, Hobbs D W, Homnick C F, Kuo M S, Lis E V, Mathre D J, Michelson S R, Pawluczyk J M, Pettibone D J, Reiss D R, Vickers S, Williams P D and Woyden C J. 19980624. Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines. : Journal of medicinal chemistry.

Harvard

Bell I. M., Erb J. M., Freidinger R. M., Gallicchio S. N., Guare J. P., Guidotti M. T., Halpin R. A., Hobbs D. W., Homnick C. F., Kuo M. S., Lis E. V., Mathre D. J., Michelson S. R., Pawluczyk J. M., Pettibone D. J., Reiss D. R., Vickers S., Williams P. D. and Woyden C. J. (19980624). Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines. : Journal of medicinal chemistry.

MLA

Bell I M, Erb J M, Freidinger R M, Gallicchio S N, Guare J P, Guidotti M T, Halpin R A, Hobbs D W, Homnick C F, Kuo M S, Lis E V, Mathre D J, Michelson S R, Pawluczyk J M, Pettibone D J, Reiss D R, Vickers S, Williams P D and Woyden C J. Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines. : Journal of medicinal chemistry. 19980624.